Canada Pension Plan Investment Board Invitae Corp Transaction History

Canada Pension Plan Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $18,375 - $45,616	-2,926 Reduced 0.08%	3,817,128 $30.4 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $14.4 Million - $28 Million	977,406 Added 34.38%	3,820,054 $58.3 Million
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $30.6 Million - $42.3 Million	1,258,564 Added 79.45%	2,842,648 $80.8 Million
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $6.04 Million - $9.35 Million	231,520 Added 17.12%	1,584,084 $53.4 Million
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $9.53 Million - $16.4 Million	288,174 Added 27.07%	1,352,564 $51.7 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $12.5 Million - $32.2 Million	1,064,390 New	1,064,390 $32.2 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.